vancomycin has been researched along with rifamycins in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (40.00) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamilton-Miller, JM | 1 |
| Liu, C | 1 |
| Markowitz, O; Razin, S; Rottem, S | 1 |
| de Repentigny, J; Lebrun, M; Mathieu, LG | 1 |
| Bartoloni, A; Colao, MG; Dei, R; Giganti, E; Orsi, A; Parenti, F | 1 |
| Gagnon, RF; Harris, A; Obst, G; Prentis, J; Richards, GK | 1 |
| Joly, P; Van der Auwera, P | 1 |
| Régnier, B | 1 |
| De Rossi, P; Isaacson, P; Lightbown, JW | 1 |
| Vacek, V | 1 |
| Chew, WH; Lockman, DS; Rissing, JP | 1 |
| Borderie, V; Bourcier, T; Laroche, L | 1 |
| HEJZLAR, M; JELINEK, J; VYMOLA, F | 1 |
| PLATTNER, HC; SCHERER, J | 1 |
| Anton, PM; Eisenstein, B; Kelly, CP; Kokkotou, E; Michaelis, A; O'Brien, M; Paraschos, S; Pothoulakis, C; Rothstein, D | 1 |
| Farquhar, R; Murphy, CK; Osburne, MS; Rothstein, DM | 1 |
| Galang, M; Gerding, DN; Johnson, S; Kelly, CP; Schriever, C | 1 |
| Jiang, W; Jiao, R; Liu, Y; Yao, Y; Yu, H; Zhao, GP | 1 |
| Cloud, JW; Espinoza, D; Kelly, CP; Kokkotou, E; Michos, A; Moss, AC; Mustafa, N; O'Brien, M; Pothoulakis, C | 1 |
| Finegold, SM; Molitoris, D; Väisänen, ML | 1 |
| Gerding, DN; Hecht, DW; Johnson, S; Patel, T; Patel, U; Schriever, C | 1 |
| Baban, TA; El-Herte, RI; Kanj, SS | 1 |
| Hsueh, PR; Ko, WC; Liao, CH; Lu, JJ | 1 |
| Babakhani, F; Bouillaut, L; Gomez, A; Nguyen, L; Sears, P; Sonenshein, AL | 1 |
| Anttila, VJ; Arkkila, P; Mattila, E; Mattila, PS; Tarkka, E; Tissari, P | 1 |
| Patel, LN; Schairer, J; Shen, B | 1 |
| Johnson, S; Soriano, MM | 1 |
| Gargvanshi, S; Gutheil, WG | 1 |
| Li, F; Lu, J; Shen, C; Wang, J; Xu, C | 1 |
| Chen, L; Lou, JM; Lu, Y; Pan, XR; Yuzuak, S; Zuo, JE | 1 |
4 review(s) available for vancomycin and rifamycins
| Article | Year |
|---|---|
Antimicrobial agents acting against anaerobes.
Topics: Aminoglycosides; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Clindamycin; Colistin; Disease Models, Animal; Erythromycin; Fusidic Acid; Humans; Lactams; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Nitroimidazoles; Polymyxins; Rifamycins; Sulfamethoxazole; Tetracyclines; Trimethoprim; Vancomycin | 1975 |
Antimicrobial therapy.
Topics: Adult; Aminoglycosides; Anti-Infective Agents; Anti-Infective Agents, Urinary; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythromycin; Humans; Imidazoles; Infant, Newborn; Lincomycin; Penicillins; Polymyxins; Rifamycins; Sulfonamides; Tetracyclines; Vancomycin | 1979 |
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Humans; Metronidazole; Minocycline; Recurrence; Rifamycins; Rifaximin; Tigecycline; Treatment Outcome; Vancomycin | 2012 |
Treatment of Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin | 2015 |
26 other study(ies) available for vancomycin and rifamycins
| Article | Year |
|---|---|
Cerulenin-induced changes in the lipopolysaccharide content and phospholipid composition of Proteus mirabilis.
Topics: Antifungal Agents; Cerulenin; Kinetics; Lipopolysaccharides; Phospholipids; Polysaccharides, Bacterial; Proteus mirabilis; Rifamycins; Vancomycin | 1978 |
[Diminution of the antibacterial activity of antibiotics in cultures and in experimental mixed infections].
Topics: Animals; Anti-Bacterial Agents; Culture Media; Cycloserine; Mice; Penicillin G; Pseudomonas aeruginosa; Pseudomonas Infections; Rifamycins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1978 |
In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Rifamycins; Ristocetin; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1990 |
The activity of rifampin and analogs against Staphylococcus epidermidis biofilms in a CAPD environment model.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Rifampin; Rifamycins; Staphylococcus epidermidis; Structure-Activity Relationship; Vancomycin | 1989 |
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Coumarins; DNA-Directed RNA Polymerases; Drug Interactions; Glycopeptides; Humans; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Teicoplanin; Topoisomerase II Inhibitors; Vancomycin | 1987 |
[Rifamycins, vancomycin and fosfomycin. A privileged use: Staphylococci resistant to methicillin].
Topics: Anti-Bacterial Agents; Fosfomycin; Methicillin; Penicillin Resistance; Rifamycins; Staphylococcus; Vancomycin | 1988 |
International standards and international reference preparations: amphotericin B, vancomycin, capreomycin, cefalotin, demethylchlortetracycline, gentamycin, gramicidin S, kanamycin and kanamycin B, lincomycin, lymecycline, methacycline, paromomycin, rifam
Topics: Amphotericin B; Anti-Bacterial Agents; Antitubercular Agents; Capreomycin; Cephalothin; Demeclocycline; Gentamicins; International Cooperation; Kanamycin; Leucomycins; Lincomycin; Lymecycline; Methacycline; Paromomycin; Rifamycins; Ristocetin; Troleandomycin; Tyrothricin; Vancomycin; World Health Organization | 1972 |
Clinical value of antistaphylococcal drugs.
Topics: Acute Disease; Anti-Infective Agents; Cephalosporins; Chronic Disease; Czechoslovakia; Drug Evaluation; Endocarditis, Bacterial; Erythromycin; Fusidic Acid; Gentamicins; Humans; Lincomycin; Novobiocin; Osteomyelitis; Penicillins; Recurrence; Rifamycins; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Vancomycin | 1973 |
Staphylococcus epidermidis endocarditis: a community-acquired methicillin-resistant isolate.
Topics: Cross Infection; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Male; Methicillin; Middle Aged; Mitral Valve; Penicillin Resistance; Rifamycins; Staphylococcal Infections; Staphylococcus; Vancomycin | 1983 |
Late bacterial keratitis after implantation of intrastromal corneal ring segments.
Topics: Adult; Clostridium Infections; Clostridium perfringens; Cornea; Corneal Stroma; Device Removal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Gentamicins; Humans; Keratitis; Prostheses and Implants; Prosthesis Implantation; Rifamycins; Staphylococcal Infections; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 2003 |
[RAPID DETERMINATION OF THE SENSITIVITY OF BACTERIA TO ANTIBIOTICS].
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Colistin; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Kanamycin; Methicillin; Neomycin; Oleandomycin; Oxacillin; Paromomycin; Penicillin G; Polymyxins; Research; Rifamycins; Staphylococcus; Streptomycin; Tetracycline; Tetrazolium Salts; Vancomycin | 1963 |
[PRESENT STATUS OF THE TREATMENT OF STAPHYLOCOCCAL DISEASES].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy; Humans; Methicillin; Oxacillin; Penicillin G; Penicillins; Probenecid; Rifamycins; Staphylococcal Infections; Vancomycin | 1965 |
Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
Topics: Animals; Anti-Bacterial Agents; Cecum; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Enzyme-Linked Immunosorbent Assay; Mesocricetus; Microbial Sensitivity Tests; Rifamycins; Secondary Prevention; Survival Analysis; Vancomycin; Weight Loss | 2004 |
In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Resistance; Microbial Sensitivity Tests; Rifamycins; Staphylococcus aureus; Time Factors; Vancomycin | 2006 |
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
Topics: Adult; Age Factors; Aged; Clostridioides difficile; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rifamycins; Rifaximin; Risk Factors; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
A complex role of Amycolatopsis mediterranei GlnR in nitrogen metabolism and related antibiotics production.
Topics: Actinomycetales; Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Glutamate-Ammonia Ligase; Nitrogen; Reverse Transcriptase Polymerase Chain Reaction; Rifamycins; Vancomycin | 2007 |
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
Topics: Animals; Anti-Infective Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Mesocricetus; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Weight Gain | 2008 |
Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.
Topics: Ampicillin; Bacteria, Anaerobic; Feces; Microbial Sensitivity Tests; Neomycin; Nitro Compounds; Rifamycins; Rifaximin; Sulbactam; Teicoplanin; Thiazoles; Vancomycin | 2009 |
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Agents; Humans; Male; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome; Vancomycin | 2009 |
Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan.
Topics: Anti-Infective Agents; Aza Compounds; Bacterial Proteins; Clostridioides difficile; Fluoroquinolones; Gemifloxacin; Glycosides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Rifamycins; Rifaximin; Taiwan; Vancomycin | 2012 |
Fidaxomicin inhibits spore production in Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Load; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Gene Expression Regulation, Bacterial; Genes, Bacterial; Metronidazole; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Spores, Bacterial; Vancomycin | 2012 |
Rifaximin in the treatment of recurrent Clostridium difficile infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Fecal transplantation therapy for Clostridium difficile-associated pouchitis.
Topics: Adult; Aminoglycosides; Child; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Humans; Male; Pouchitis; Rifamycins; Rifaximin; Vancomycin | 2014 |
Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Rifabutin; Rifamycins; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Deciphering the mechanisms shaping the plastisphere antibiotic resistome on riverine microplastics.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Genes, Bacterial; Microplastics; Plastics; Polyethylene Terephthalates; Rifamycins; Vancomycin; Water | 2022 |
Microbial community and antibiotic resistance gene distribution in food waste, anaerobic digestate, and paddy soil.
Topics: Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Bacitracin; Bacteria; Drug Resistance, Microbial; Food; Genes, Bacterial; Microbiota; Refuse Disposal; Rifamycins; Soil; Tetracyclines; Vancomycin | 2023 |